This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (93)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

The Copenhagen AFASAK Study

Palle Petersen, MD; Jens Kastrup, MD, PhD; Susanne Helweg-Larsen, MD; Gudrun Boysen, MD, PhD; John Godtfredsen, MD, PhD

Arch Intern Med. 1990;150(4):819-821.

Abstract
• As previously reported, 1007 patients with chronic atrial fibrillation participated in the Copenhagen AFASAK study. Before inclusion to trial, they all had a physical examination, chest roentgenogram, and echocardiogram with determination of left atrial size. This study evaluated the importance of cardiovascular risk factors for development of thromboembolic complications. To exclude any treatment effects on occurrence of thromboembolic complications, we included only the 336 patients from the placebo group. Using Cox's regression model, previous myocardial infarction was a significant risk factor for development of thromboembolic complications. Age, gender, heart failure, chest pain, hypertensive heart disease, diabetes, systolic and diastolic blood pressure, smoking, relative heart volume, and left atrial size were all without statistical importance.

(Arch Intern Med. 1990;150:819-821)

Author Affiliations
From the Departments of Neurology (Drs Petersen, Helweg-Larsen, Boysen, and Godtfredsen) and Cardiology (Dr Kastrup), University Hospital, Rigshospitalet, Copenhagen, Denmark.

Footnotes
Accepted for publication October 30,1989.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Coronary Artery Disease and Ischemic Stroke in Atrial Fibrillation
Lip
Chest 2007;132:8-10.
FULL TEXT  

The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation
Shelton et al.
Eur Heart J 2006;27:2353-2361.
ABSTRACT | FULL TEXT  

Electrocardiographic Left Atrial Abnormalities and Risk of Ischemic Stroke
Kohsaka et al.
Stroke 2005;36:2481-2483.
ABSTRACT | FULL TEXT  

Are Transthoracic Echocardiographic Parameters Associated With Atrial Fibrillation Recurrence or Stroke?: Results From the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
Olshansky et al.
J Am Coll Cardiol 2005;45:2026-2033.
ABSTRACT | FULL TEXT  

Management of the Older Person With Atrial Fibrillation
Aronow
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2002;57:M352-363.
ABSTRACT | FULL TEXT  

Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
Hart and Halperin
ANN INTERN MED 1999;131:688-695.
ABSTRACT | FULL TEXT  

Left Atrial Size and the Risk of Ischemic Stroke in an Ethnically Mixed Population
Di Tullio et al.
Stroke 1999;30:2019-2024.
ABSTRACT | FULL TEXT  

Management of Patients With Atrial Fibrillation : A Statement for Healthcare Professionals From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association
Prystowsky et al.
Circulation 1996;93:1262-1277.
FULL TEXT  

Cost-effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients With Nonvalvular Atrial Fibrillation
Gage et al.
JAMA 1995;274:1839-1845.
ABSTRACT  

How To Do It: Service provision and use of anticoagulants in atrial fibrillation
Sudlow et al.
BMJ 1995;311:558-560.
FULL TEXT  

Left Atrial Size and the Risk of Stroke and Death : The Framingham Heart Study
Benjamin et al.
Circulation 1995;92:835-841.
ABSTRACT | FULL TEXT  

Predictors of Major Vascular Events in Patients With a Transient Ischemic Attack or Minor Ischemic Stroke and With Nonrheumatic Atrial Fibrillation
van Latum et al.
Stroke 1995;26:801-806.
ABSTRACT | FULL TEXT  

Radiofrequency Catheter Ablation of the Atria Reduces Inducibility and Duration of Atrial Fibrillation in Dogs
Elvan et al.
Circulation 1995;91:2235-2244.
ABSTRACT | FULL TEXT  

Anticoagulation in Atrial Fibrillation: Does Efficacy in Clinical Trials Translate Into Effectiveness in Practice?
Gottlieb and Salem-Schatz
Arch Intern Med 1994;154:1945-1953.
ABSTRACT  

Silent Brain Infarction and Coronary Artery Disease in Japanese Patients
Tanaka et al.
Arch Neurol 1993;50:706-709.
ABSTRACT  

Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Inves
ANN INTERN MED 1992;116:1-5.
ABSTRACT  

Predictors of Thromboembolism in Atrial Fibrillation: II. Echocardiographic Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Inves
ANN INTERN MED 1992;116:6-12.
ABSTRACT  

Stroke Prevention in Nonvalvular Atrial Fibrillation
Albers et al.
ANN INTERN MED 1991;115:727-736.
ABSTRACT  

Physicians' Attitudes Toward Oral Anticoagulants and Antiplatelet Agents for Stroke Prevention in Elderly Patients With Atrial Fibrillation
Kutner et al.
Arch Intern Med 1991;151:1950-1953.
ABSTRACT